Benchling, which makes software for tracking and managing data from biotech research, raises $50M at a $850M valuation, bringing its total raised to $114M
Sajith Wickramasekara started working on an idea for a cloud-based Crispr design tool for scientists during college at MIT eight years ago.
Lux's @BrandonReeves08 on Lux family co @benchling “We invest in so much biotech that spends money on Benchling—it's become a line item like how Salesforce CRM is for enterprise IT.” (Credit to @benchmark + Thrive backing incredible CEO Sajith first!) https://www.forbes.com/...
So many broken workflows being replaced by purposed built SaaS apps, but few with the opportunity to have as important of an impact on humanity! “Biotech R&D Software Startup @Benchling, Scores $850M Valuation” via @forbes https://www.forbes.com/...
One of the untold stories of the SaaS explosion is as new areas are “quantified,” new “systems of record” are created. And those SoR have created the largest enterprise companies. Am loving working with @Benchling, a new SoR for life sciences R&D. @forbes https://www.forbes.com/.…